Approaches to cancer treatment developed by MD Anderson researchers as part of the institution’s Moon Shots Program will be, in part, the focus of two new Dream Teams announced by Stand Up to Cancer (SU2C), a national organization launched by film and media leaders to speed development of cancer treatments.

The researchers will test combinations of targeted therapy and immunotherapy against lung cancer driven by intractable KRAS...

The cost of treating people infected with the hepatitis C virus (HCV) with newly approved therapies will likely place a tremendous economic burden on the country’s health care system.

The prediction comes from a cost-effectiveness analysis led by researchers at MD Anderson. The findings, reported in the Annals of Internal Medicine, predict that the cost of providing patients their daily regimens could total $90 billion over five...